The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery?
Abstract
Studies have shown that antifibrinolytic (aprotinin, tranexamic acid, epsilon-aminocaproic acid) reduce blood loss in orthopedic surgery. However, most lacked sufficient power to evaluate the efficacy and safety on clinical outcomes. This meta-analysis aims to evaluate whether intravenous antifibrinolytics, when compared with placebo, reduce perioperative allogeneic erythrocyte transfusion requirement in adults undergoing orthopedic surgery and whether it might increase the risk of venous thromboembolism. From MEDLINE, EMBASE, and the Cochrane Controlled Trials Register, the authors identified 43 randomized controlled trials in total hip and knee arthroplasty, spine fusion, musculoskeletal sepsis, or tumor surgery performed to July 2005 (for aprotinin, 23 trials with 1,268 participants; tranexamic acid, 20 with 1,084; epsilon-aminocaproic acid, 4 with 171). Aprotinin and tranexamic acid reduced significantly the proportion of patients requiring allogeneic erythrocyte transfusion according to a transfusion protocol. The odds ratio was 0.43 (95% confidence interval, 0.28-0.64) for aprotinin and 0.17 (0.11-0.24) for tranexamic acid. Results suggest a dose-effect relation with tranexamic acid. Epsilon-aminocaproic acid was not efficacious. Unfortunately, data were too limited for any conclusions regarding safety. Although the results suggest that aprotinin and tranexamic acid significantly reduce allogeneic erythrocyte transfusion, further evaluation of safety is required before recommending the use of antifibrinolytics in orthopedic surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309 · cited 1×
“Therefore, we explored the robustness of our findings through sensitivity analyses.(75) Because these analyses did not suggest that the open-label trials or any individual trial exaggerated the magnitude of the estimated treatment effect of aprotinin or tranexamic acid, Fig.”
ResultInvestigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
The Risk Associated with Aprotinin in Cardiac Surgery
Mangano, D. T., Tudor, I. C., & Dietzel, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051379 · Cited by 1,099
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
Henry, D. A., Carless, P. A., Moxey, A. J., O’Connell, D. L., Stokes, B., Fergusson, D. A., & Ker, K. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001886.pub4 · Cited by 1,065
Hill, G. E., Frawley, W. H., Griffith, K. E., Forestner, J. E., & Minei, J. P. (2003) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000022460.21283.53 · Cited by 556
Cell salvage for minimising perioperative allogeneic blood transfusion
Carless, P. A., Henry, D. A., Moxey, A. J., O’Connell, D. L., Brown, T. J., & Fergusson, D. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001888.pub4 · Cited by 462
Wood, M., Mantilla, C. B., Horlocker, T. T., Schroeder, D. R., Berry, D. J., & Brown, D. L. (2002) · Anesthesiology · doi:10.1097/00000542-200205000-00017 · Cited by 349
Eliminating Blood Transfusions: New Aspects and Perspectives
Spahn, D. R., & Casutt, M. (2000) · Anesthesiology · doi:10.1097/00000542-200007000-00035 · Cited by 267
A Randomized Trial of Tranexamic Acid to Reduce Blood Transfusion for Scoliosis Surgery
Neilipovitz, D. T., Murto, K., Hall, L., Barrowman, N. J., & Splinter, W. M. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200107000-00018 · Cited by 257
Ho, K. M., & Ismail, H. (2003) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0303100507 · Cited by 231
Cited by
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Self-citationTranexamic Acid: A Review of its Use in the Treatment of Hyperfibrinolysis
McCormack, P. L. (2012) · Drugs · doi:10.2165/11209070-000000000-00000 · Cited by 640
Poeran, J., Rasul, R., Suzuki, S., Danninger, T., Mazumdar, M., Opperer, M., Boettner, F., & Memtsoudis, S. G. (2014) · BMJ · doi:10.1136/bmj.g4829 · Cited by 477
Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement
Sukeik, M., Alshryda, S., Haddad, F. S., & Mason, J. M. (2011) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.93b1.24984 · Cited by 428
Yang, Z.-G., Chen, W.-P., & Wu, L.-D. (2012) · The Journal of Bone & Joint Surgery · doi:10.2106/jbjs.k.00873 · Cited by 416
Metadata
- Authors
- Zufferey, P., Merquiol, F., Laporte, S., Decousus, H., Mismetti, P., Auboyer, C., Samama, C. M., Molliex, S., & Warltier, D. C.
- Venue
- Anesthesiology
- Published
- 2006-11-01
- Volume
- 105
- Issue
- 5
- Pages
- 1034-1046
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2100730818
- Cited by
- 340
- References
- 14
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery? https://app.cochat.ai/papers/10.1097/00000542-200611000-00026
- The paper
- Zufferey, P., Merquiol, F., Laporte, S., Decousus, H., Mismetti, P., Auboyer, C., Samama, C. M., Molliex, S., & Warltier, D. C. (2006). Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery? Anesthesiology. https://doi.org/10.1097/00000542-200611000-00026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.